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Abstract
Objective—Long-term, high-level exposure to manganese (Mn) is associated with impaired 
central nervous system (CNS) function. We quantitatively explored relations between low-level 
Mn exposure and selected neurological outcomes in a longitudinal inception cohort of 
asymptomatic welder trainees.
Methods—Welders with no previous occupational Mn exposure were observed approximately 
every three months over the course of the five-quarter traineeship. Fifty-six welders were assessed 
for motor function using the Unified Parkinson Disease Rating Scale motor subsection part 3 
(UPDRS3) and Grooved Pegboard tests. A subset of 17 also had MRI scans to assess T1-weighted 
indices. Personal exposure to Mn in welding fume was quantitatively assessed during the study 
period using a mixed model to obtain estimates of subject-specific exposure level by welding type. 
These estimates were summed to estimate cumulative exposure at the time of each neurological 
outcome test.
Results—When adjusting for possible learning effects, there were no associations between 
cumulative exposure and UPDRS3 score or Grooved Pegboard time. T1-weighted indices of the 
basal ganglia (caudate, anterior putamen, posterior putamen, and combined basal ganglia, but not 
the pallidal index) exhibited statistically significant increases in signal intensity in relation to 
increased cumulative Mn exposure.
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Conclusions—This study demonstrates that T1-weighted changes can be detected in the brain 
even at very low levels of exposure among humans before any clinically evident deficits. This 
suggests that with continued follow-up we could identify a T1 threshold of toxicity at which 
clinical symptoms begin to manifest.
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Elevated exposure to manganese (Mn) has long been an occupational health concern; excess 
Mn in the body crosses the blood-brain barrier, accumulates in the brain, and can cause 
adverse neurological health effects (1, 2). Manganism is a syndrome characterized by 
parkinsonism features (bradykinesia, rigidity, postural instability, tremor), dystonia, and 
cognitive dysfunction, clinical features also common to idiopathic Parkinson’s disease (3).
Welders typically experience 8-hour mean personal breathing zone Mn concentrations 
ranging from <0.02–>1.0 mg/m3, depending on welding process and control methods (4–7). 
The American Conference of Governmental Industrial Hygienists’ (ACGIH) 8-hour time-
weighted average threshold limit value (TWA TLV) for Mn in total inhalable dust was 
recently reduced to 0.1 mg/m3 and the respirable TLV was reduced to 0.02 mg/m3, based on 
neurological outcomes seen in workers exposed to low levels of Mn (8). Although welding 
fume is almost entirely respirable, other metalworking tasks commonly done by welders 
generate larger, inhalable particles. However, the Occupational Safety and Health 
Administration’s Permissible Exposure Limit (OSHA PEL) for Mn in total inhalable dust of 
5.0 mg/m3 (ceiling) is the only enforceable Mn standard in the United States. In Europe, the 
European Commission Scientific Committee on Occupational Exposure Limits (SCOEL) 
recommends an 8-hour TWA of 0.2 mg/m3 for Mn in the inhalable fraction and 0.05 mg/m3 
for Mn in the respirable fraction, though enforceable standards would vary between 
European countries (9).
Manganism has historically been associated with long-term, high levels of occupational 
exposure to Mn, yet neurological effects have been observed at Mn levels below the OSHA 
PEL and closer to the ACGIH TLV or SCOEL recommended 8-hour TWA (10–12). 
Recently, Laohaudomchok et al (13) reported parkinsonian effects among welders who 
experience low Mn exposures (median: 0.013 mg/m3). Ellingsen et al (14) found welders 
with a mean Mn exposure of 0.21 mg/m3 to have poorer performance than unexposed 
referents on Grooved Pegboard, Finger Tapping, and Simple Reaction Time tests. In 
contrast, among both mineworkers and smelter workers exposed to Mn, Myers et al (15, 16) 
found no relationship between Mn exposure and nervous system effects, even at levels 
above the ACGIH TLV.
While neurological function tests, such as UPDRS3 and Grooved Pegboard, are classified as 
biomarkers of Mn effect, T1-weighted magnetic resonance images (MRI) have been utilized 
as a biomarker of Mn in-vivo brain exposure. Mn is a paramagnetic element that strongly 
influences the magnetic resonance properties of surrounding tissues. Mn shortens tissue T1 
relaxation times resulting in increased signal intensity detectible on T1-weighted imaging. 
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Human studies have confirmed the intensity of the T1 pallidal signal correlates with blood 
Mn levels and cumulative exposure to Mn, but it may not be as accurate at low levels of 
chronic exposure (17–19). A recent paper by Criswell et al (20) found intensity changes in 
the caudate and putamen to be better markers of cumulative exposure. In this study we 
attempt to evaluate caudate, putamen, and pallidal T1 signal as markers of low-level Mn 
exposure in a longitudinal study of welder trainees.
Many tests exist to assess neurotoxicity associated with Mn exposure, both specific (ie, 
functional imaging techniques, neuropsychiatric testing for domains of memory) and general 
(ie, some tests of mood, dexterity), that have been used either singularly or as part of a 
battery (3, 21–23). Epidemiologic studies assessing neurological outcomes associated with 
Mn exposure among welders and other occupationally exposed groups are most commonly 
cross-sectional. Although non-exposed referent groups are frequently included, to our 
knowledge no prior studies have included pre-exposure baseline measurements of CNS 
function on a well-characterized Mn-exposed occupational cohort. While a longitudinal 
inception cohort study of neurological function allows for individuals to serve as their own 
controls, the performance-based tests also raise the possibility of learning effects, which can 
obscure changes over time (24).
In this study, we employed three methods to longitudinally assess CNS function in a cohort 
of previously unexposed welders exposed to low levels of Mn: (i) the Grooved Pegboard 
examination to assess dexterity and fine motor control (25), (ii) UPDRS3 for parkinsonian 
signs such as rest and postural tremor, bradykinesia, and gait disturbance (26), and (iii) T1-
weighted brain MRI, an in-vivo measure of Mn exposure (20, 27). The purpose of this 
manuscript is to explore neurological outcomes associated with low-level cumulative 
exposures to Mn in a longitudinal cohort of asymptomatic welder trainees.
Methods
Occupational setting and study population
Subjects included 56 welder trainees enrolled in a 5-quarter welding training program at a 
technical college in Washington State who joined our cohort prior to occupational exposure 
to Mn. All 56 enrolled subjects underwent longitudinal UPDRS3 and Grooved Pegboard 
tests, and 17 underwent repeat MRI measures. Details of the cohort study and the welding 
traineeship have been previously described (28). In accordance with the Helsinki 
Declaration, the University of Washington (UW) Institutional Review Board and UW 
Human Research Protection Office reviewed and approved all study protocols, and subjects 
provided written informed consent. Data collection for the study began in April 2011 and 
was completed in June 2013.
Upon entry to the study, and at the end of each academic quarter (approximately ten weeks), 
all subjects completed the Grooved Pegboard test and UPDRS3 examination. Similarly, 
upon entry and at the end of each academic quarter, those subjects enrolled in the MRI sub 
cohort were transported to UW Medical Center (UWMC, Seattle, WA, USA) for MRI scans. 
On completion of the study, co-investigators at Washington University (WU, St Louis, MO, 
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USA) interpreted all UPDRS3 examinations and MRI scans, which had been stripped of any 
time- or subject-identifying information.
Grooved Pegboard
Trained research staff administered the Grooved Pegboard (Lafayette Instrument Evaluation, 
West Lafayette, IN, USA) examination on each subjects’ dominant and non-dominant hand, 
following the procedure outlined by the Grooved Pegboard’s user’s manual (25, 29). A 
higher score (longer time to complete the test) indicates reduced dexterity and fine motor 
control.
Unified Parkinson Disease Rating Scale, motor subsection part 3
Each subject was videotaped completing the UPDRS3 examination, except for rigidity. 
Videos were rated by a movement disorders specialist blinded to the exposure and clinical 
status of the subject (26, 30). If the video quality did not allow an individual item to be 
graded, that subject’s total score was not able to be calculated, and thus was not included in 
analyses. Five UPDRS3 examinations from five different subjects were missing a measure 
of tremor, likely at random and not affecting our outcome analyses.
Magnetic resonance imaging
Subjects interested in participating, and with no contraindications to MRI, were enrolled in 
the MRI sub cohort and transported to UW Diagnostic Imaging Sciences Center at the end 
of the workday where MRI scans were conducted on a 3T Philips Achieva MR System. 
Structural anatomic scans included a T1-weighted sagittal, magnetization-prepared rapid 
gradient echo [MPRAGE; repetition time (TR)=20.0 ms; inversion time (TI)=1000 ms, echo 
time (TE)=3.14 ms, flip angle=8°, 0.9×0.9×0.9 mm voxels] and, as is standard, T2-weighted 
indices were also measured. However, results from T2-weighted imaging are not 
informative in relation to Mn exposure and are not presented.
A reviewer blinded to the clinical and exposure status of the subject outlined volumes of 
interest (VOI) on individual MR images including bilateral caudate, globus pallidus, anterior 
putamen, posterior putamen, and then calculated a combined basal ganglia as the average 
signal of all the above VOI. The intensity of the signal on the T1 weighted image in the VOI 
was compared to standard frontal white matter control regions by calculating an intensity 
index (see equation 1) for each subject. Regional indices were calculated from the T1 
MPRAGE images as previously described for the pallidal index (PI) (31).
(equation 
1)
All MRI were screened for neurological abnormalities at UW prior to interpretation by WU 
co-investigators.
Estimating manganese exposure in air
The subject was enrolled in the study four times during each quarter and fitted with a 
personal air pump (SKC AirChek XR4000, Eighty Four, PA, USA) with an attached pre-
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weighed 37 mm 0.8 µm pore mixed cellulose ester filter hung in their breathing zone, 
outside the welding helmet. The pumps operated at a flow of 2.0 L/min, which was 
measured at the beginning and end of each full-shift sampling period. Subjects completed an 
exposure questionnaire to assess type of welding, use of respiratory protection, and 
confounding sources of Mn exposure. Air filters were analyzed gravimetrically for total 
particulate mass, then digested and analyzed for trace metals by inductively coupled plasma 
mass spectrometry (ICP-MS) at the UW Environmental Health Laboratory (32). Reporting 
limits for Mn ranged from 0.01–0.03 µg, depending on analysis-batch-specific field blanks, 
and were based on three times the standard deviation of the blanks, which were treated the 
same as the samples in the field. No air samples fell below the reporting limit.
We calculated 8-hour TWA Mn concentrations, lntransformed the concentrations, and a 
mixed model was fit to obtain estimates of exposure level by welding type (fixed effect), 
adjusted for subject (random effect). These estimates were used to predict 8-hr TWA Mn 
exposure levels, based on the type of welding subjects self-reported to be doing each day of 
their enrollment. Weekends, vacation days, and days the subjects were absent (as ascertained 
from school attendance records) were coded as zero exposure. On days when a neurological 
function test occurred, all preceding predicted daily exposures were summed to create a 
predicted cumulative exposure from time of entry into the program to the day of the 
neurological function test, in units of mg/m3-day.
Statistical analysis
The associations between predicted cumulative exposure at the time of the test and each 
neurological outcome of interest were assessed using longitudinal linear mixed-effects 
models allowing for subject as a random effect. For UPDRS3, the neurological outcome of 
interest was the total UPDSR3 score. As gender is a well-established effect modifier for the 
Grooved Pegboard (33, 34), and only four females were enrolled in our study, pegboard 
models of dominant hand time are only presented for males (number of subjects=52).
There was only one female in the MRI sub cohort, but removing her four scans from the 
mixed models did not affect the regression coefficients relating exposure and outcome, thus 
she is included in all MRI models. While several covariates were considered in the mixed 
models (including smoking status, alcohol drinker, prior self-reported loss of consciousness, 
self-reported respirator use, and age at baseline), the only covariate significant in any model 
was age at baseline, which was found to contribute significantly to the Grooved Pegboard 
models and some of the MRI models. Thus, all models were adjusted for subject age at 
baseline.
Because subjects underwent repeat measures of UPDRS3 and Pegboard over fairly short 
time periods (mean time between examinations was 66 days), we hypothesized changes in 
score that appear to be associated with cumulative exposure may in fact be influenced by a 
learning effect. Therefore, in addition to crude models unadjusted for a learning effect, we 
also adjusted the UPDRS3 and Pegboard models to control for a potential learning effect. To 
accomplish this, we corrected the existing models for three predictors, based on guidance 
from McKnight et al (35): number of previous tests (continuous), months since previous test 
(continuous), and a binary indication of whether or not it was the first test (first test=0, 
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subsequent tests=1). All data analysis was done at UW using Stata 12 (Stata Corp LP, 
College Station, TX, USA).
Results
Demographic characteristics for the entire welding cohort and MRI sub cohort are 
summarized in table 1. The MRI sub cohort was similar to the entire cohort. Measured 8-hr 
TWA Mn concentrations (N=600) ranged from 0.2–208 µg/m3 [geometric mean 16.5, 
geometric standard deviation (GSD) 3.4] Only 4.5% of all samples (N=27) exceeded the 
ACGIH inhalable TLV of 0.1 mg/m3, but assuming Mn in welding fume is primarily in the 
respirable range (36), 51.8% of all samples (N=211) exceeded the ACGIH respirable TLV 
of 0.02 mg/m3.
Predicted 8-hr TWA Mn concentrations, which were modeled from the measured 8-hr TWA 
Mn concentrations, ranged from 4.1–68.6 µg/m3 (geometric mean 15.7, GSD 2.2). The 
modeled exposure values were subsequently used to estimate cumulative exposure.
Table 2 summarizes the neurological outcomes for all time points. None of the pegboard 
times were outside of the typical reference ranges, based on age and gender (29, 34, 37). 
Similarly, none of the UPDRS3 scores were indicative of definite or probable parkinsonism 
(>15), though N=14 (5.3%) of the UPDRS3 scores were >6, a mildly elevated score (26). 
The average subject underwent 3.8 [standard deviation (SD) 1.7] Grooved Pegboard tests 
(range 1–7) and 3.7 (SD 1.6) UPDRS3 examinations (range 1–7). The average subject in the 
MRI sub cohort underwent 3.7 (SD 1.6) MRI scans (range 1–7).
Table 3A shows coefficients of association between predicted cumulative exposure and 
time-to-complete the pegboard test for males using their dominant hand. For males of a 
similar age completing the pegboard test with their dominant hand, each 1 mg/m3-day 
increase in cumulative exposure is associated with, on average a −0.60 second [95% 
confidence interval (95% CI) −1.00–−0.21] faster completion of the test. When adjusting 
this model to control for a learning effect, the coefficient of association between cumulative 
exposure and time to complete the pegboard test was similar (−0.68, 95% CI −1.6–0.27), 
however the 95% confidence interval indicates that the unadjusted negative association was 
influenced by a learning effect.
Similar relationships were seen for males using their non-dominant hand (not shown). In 
both unadjusted and adjusted pegboard models, age at baseline was a significant contributor 
to the model, and when adjusting for a learning effect, an increase in months between tests 
resulted in a slight but significant increase in time to complete the test, an average of 1.22 
seconds slower (95% CI 0.27–1.83).
Table 3B shows coefficients of association between predicted cumulative exposure and total 
UPDRS3 score, both adjusted for a learning effect and unadjusted. In the unadjusted model, 
a 1 mg/m3-day increase in cumulative exposure was associated with a −0.12 point lower 
score (95% CI −0.21–0.04). However, in the adjusted model, the association between 
UPDRS3 score and cumulative exposure indicates that this test was also influenced by a 
learning effect.
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Table 4 shows the associations between cumulative exposure and MRI outcomes. Among 
the MRI outcomes, caudate, anterior putamen, posterior putamen, and combined basal 
ganglia T1 indices were all increased significantly in relation to increased cumulative Mn 
exposure. The T1 PI did not show any changes associated with low level cumulative 
exposure. For subjects of a similar age, a 1 mg/m3-day increase in cumulative Mn exposure 
was associated with, on average, a caudate T1 index with an increased signal intensity of 
0.31 (95% CI 0.14–0.48), an anterior putamen T1 index with an average increased signal 
intensity of 0.26 (95% CI 0.10–0.41), a posterior putamen T1 index with an average 
increased signal intensity of 0.22 (95% CI 0.08–0.36), and a combined basal ganglia T1 
index with an average increased signal intensity of 0.18 (95% CI 0.07–0.30). These average 
increases correspond to a 0.4% increase from the baseline mean caudate T1 index, a 0.3% 
increase from the baseline mean anterior putamen T1 index, and a 0.2% increase from both 
the baseline mean posterior putamen and combined basal ganglia T1 indices.
One subject exhibited a large change between their penultimate and last MRI, the only 
instance of at least a 10% change between two subsequent scans for any T1 measures among 
any of the subjects. The findings were not materially changed when sensitivity analyses 
were performed excluding this subject.
Discussion
To our knowledge, this is first study to longitudinally explore changes to the CNS associated 
with Mn exposure among subjects who (i) were asymptomatic at baseline, (ii) had no prior 
occupational exposure to Mn, and (iii) had known baseline measures. The three methods of 
assessing neurological outcomes we selected allowed us to evaluate markers of in-vivo Mn 
exposure (MRI), clinical measures of parkinsonism (UPDRS3), and clinical measures of fine 
motor skill/dexterity (Grooved Pegboard). As a condition of entry into the study, all subjects 
were deemed asymptomatic, as assessed by a health screening questionnaire. Baseline 
UPDRS3 and Grooved Pegboard examinations confirmed subjects to be clinically normal, 
as UPDRS3 scores were within the normal range (26), and Grooved Pegboard completion 
times were within typical age- and gender-specific reference ranges. Twenty-five percent of 
the cohort self-reported using respirators. However, field research staff observed very poor 
respirator practices; for example, no fit testing or respiratory protection training was 
provided on site, subjects failed to regularly change cartridges, and frequently wore them 
inconsistently or incorrectly. Thus, even though respirators were used, the degree of 
protection would not be as much as expected under ideal circumstances. Nevertheless, we 
tested the impact of respiratory protection on the exposure–response relationship and no 
effect was observed on either the outcome or the relationship between the exposure and 
outcome.
Unadjusted findings from the UPDRS3 and Grooved Pegboard mixed models indicated a 
tendency for pegboard time and UPDRS3 score to be inversely related to cumulative 
exposure. However, when adjusting for a learning effect, these relationships were no longer 
apparent. Time since enrolling in the study and cumulative exposure are, unsurprisingly, 
highly correlated (Pearson’s r=0.84). Thus, being able to parse out the effects of increased 
Mn exposure on Pegboard time or UPDRS3 score from the effects of repeat tests over a 
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fairly short time period in a longitudinal study is challenging. However, it is apparent for 
both pegboard and UPDRS3 that, over the relatively short time periods we repeatedly 
administered these tests, there were no meaningful changes with increased exposure to 
airborne Mn. In contrast, we did observe hypothesized associations of cumulative exposure 
with MRI patterns, which are not subject to learning or time effects.
Despite exposure at or near the ACGIH respirable TLV, there was an apparent increase in 
T1 signal intensities for several parts of the basal ganglia (ranging from a 0.2–0.4% increase 
over the mean) indicative of in-vivo effects associated with Mn exposure. Thus, it appears 
that even at very low levels of occupational exposure, changes associated with Mn exposure 
are apparent via MRI techniques, before clinical measures (such as those assessed via 
UPDRS3 and Grooved Pegboard) manifest, or can overcome influences from time and 
learning.
Our results corroborate with those reported by Criswell et al (20) among career professional 
welders, in which the caudate, putamen, and basal ganglia indices all demonstrated stronger 
correlations with Mn exposure than the PI, especially at low levels of Mn exposure. Animal 
and human studies demonstrated Mn deposition throughout all parts of basal ganglia (38, 
39). These studies and our results suggest that while earlier studies have focused on the 
pallidum as the primary target of Mn exposure (as characterized by the PI), the caudate and 
putamen may be the better regions to serve as biomarkers of Mn exposure.
Our study design is a primary strength of our study, given it is, to our knowledge, the first 
inception cohort design to assess CNS related to Mn in a well-characterized, asymptomatic 
cohort. The controlled nature of the welding training program and repeat full-shift personal 
air samples allowed us to predict subject-specific cumulative exposures at any time point, 
and we sampled longitudinally for both biomarkers of exposure and effect related to Mn 
neurotoxicity. However, we only followed subjects during the time they were in the welding 
training program. Over this relatively short time period, at the low-levels of exposures we 
observed among our young and otherwise healthy subjects, we wouldn’t expect clinical 
indications of parkinsonism to manifest, even with sustained exposure to Mn. Because our 
cohort consisted of welder apprentices, exposures and work scenarios are not necessarily 
representative of standard occupational welding settings where exposures would be higher, 
more variable, and less controlled.
Several studies have reported resolution of T1 hyper intensities among occupationally 
exposed workers after removal from the source of Mn exposure. Despite improvement in 
their T1 imaging characteristics, clinical deficits in these workers, if present, frequently 
persist (40–42). This suggests while the increased T1 signal intensity is potentially 
reversible, there may be an exposure threshold at which the MRI changes and neurotoxic 
effects become permanent.
In conclusion, this study showed that even with 8-hr TWA Mn exposures at or below the 
ACGIH recommendations, there were increases in T1-weighted indices in the caudate, 
anterior and posterior putamen, and combined basal ganglia, that were significantly related 
to increases in cumulative Mn exposure among asymptomatic welder apprentices. However, 
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there were no clinical signs of neurological dysfunction related to increases in cumulative 
Mn exposure at these low levels and over this relatively short time period as assessed via 
UPDRS3 and Grooved Pegboard. T1-weighted PI (but not other indices) has been correlated 
with the Grooved Pegboard (dominant hand) in one cross-sectional study, but other indices 
have not yet been correlated with clinical measures of parkinsonism, and toxicologically 
relevant reference values for T1-weighted indices have not yet been established for exposed 
persons (18). As none of our subjects exhibited clinical signs of parkinsonism we cannot 
address the relationship between MRI outcomes and clinical manifestations of parkinsonism 
with our cohort. Previously, T1-weighted MRI measures have been positively correlated 
with Mn exposure, though not at levels as low as in our study or with repeat measurements 
in a well-characterized inception cohort such as ours. Our study offers additional converging 
evidence that Mn exposure is associated with T1 signal intensity in various parts of the basal 
ganglia, making T1-weighted MRI (especially in the caudate/putamen) a biomarker of 
exposure to Mn, seemingly sensitive across a wide range of exposure levels, and relatively 
short time periods.
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Table 4
Association of T1 weighted magnetic resonance imaging (MRI) indices with cumulative exposure, adjusted 
for age at baseline. [95% CI=95% confidence interval; SD=standard deviation.]
MRI score/
(mg/m3-days)
ß 95% CI Within
SD a
Between
SD a
Caudate T1 0.31 0.14–0.48 1.5 1.8
Anterior putamen T1 0.25 0.10–0.41 1.3 2.3
Posterior putamen T1 0.22 0.08–0.36 1.2 2.9
Basal ganglia T1 0.18 0.06–0.29 1.0 2.3
Pallidal Index T1 −0.04 −0.22–0.14 1.6 2.3
a
From mixed effects restricted maximum likelihood (REML) regression.
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